Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke - Wikidata - awgldk - TriplyDB

Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke

Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke

http://www.wikidata.org/entity/Q33714865

about

Vascular protection to increase the safety of tissue plasminogen activator for stroke Window of opportunity: estrogen as a treatment for ischemic stroke Evaluation of combination therapy in animal models of cerebral ischemia Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model.Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice.Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats Angiogenesis in old-aged subjects after ischemic stroke: a cautionary note for investigators Potential age-dependent effects of estrogen on neural injury Demethylation of Circulating Estrogen Receptor Alpha Gene in Cerebral Ischemic Stroke.Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury Does inhibiting Sur1 complement rt-PA in cerebral ischemia?17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke.Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.Impact of methodology on estrogens' effects on cerebral ischemia in rats: an updated meta-analysis.Neuroprotective effects of estrogen in CNS injuries: insights from animal models Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein.Neuroprotective effect of masitinib in rats with postischemic stroke.Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.

P2860

Q26824338-51384CD5-A4C8-4EC1-9017-BF68AC492A9F Q26828794-1ED34FF2-A48D-4687-8777-2EE9C5134EB7 Q27025781-AE495C61-A96B-464A-9202-AF19654FCC3E Q28397361-65D8DB2C-F3C3-4460-A98A-925B73DAB322 Q30548210-B9DA777B-396F-4827-8994-5034A93C2FAD Q33643959-FAEE9CD2-8F72-4084-A46F-DD18F6B066C3 Q33883134-08FF05B4-3C7B-4580-ABE9-9B3007B94974 Q34006140-20D53DF3-3D91-44A3-9997-94E05DB603E5 Q34201028-B2892FFC-6380-4BEC-AD46-D2EEB8FA87D3 Q34397776-03BA52DA-D753-4F9E-B941-00B34A55D596 Q35071491-C2D21EBA-B4BD-4D95-9AA7-8E12CD7D42C8 Q35793874-2EBEEF99-C769-4327-A8C3-AC376E2DEF8B Q35910801-9580D8E9-7F82-4053-AE4F-32C72A2D3E2E Q36426567-6DFBDD58-4308-4DEE-9A79-D2AFCCEDB3EC Q36555588-AF7FA459-1081-4ED9-97A8-B22E36D59D7D Q36931700-C33C3A2A-CC26-4D4E-B95B-E32EBD03F4CD Q37293625-1A35E358-96E4-490D-89B9-D3802D7E9A96 Q37685164-D3E0CCA6-BB64-460F-8B9A-F491BDDC4DB2 Q38636826-57CEF232-1200-4D37-AAA5-3479267A9A56 Q41879921-69C48B48-4C99-4875-B184-CAEA03E45877 Q43091544-55A9AD18-05B5-49F2-8FE0-BB77AECE0776 Q52148119-4B1641D9-D7A6-4378-A6CF-5A16938AE1BB

P2860

Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke

http://www.wikidata.org/entity/Q33714865

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Combination therapy of 17beta- ...... r experimental ischemic stroke

@ast

Combination therapy of 17beta- ...... r experimental ischemic stroke

@en

type

label

Combination therapy of 17beta- ...... r experimental ischemic stroke

@ast

Combination therapy of 17beta- ...... r experimental ischemic stroke

@en

prefLabel

Combination therapy of 17beta- ...... r experimental ischemic stroke

@ast

Combination therapy of 17beta- ...... r experimental ischemic stroke

@en

P1433

Q33714865-0D717A30-145D-41FF-AECA-0532F80B97AD

P1476

Q33714865-1A230416-59F6-4D26-B208-11555F13001A

P2093

Q33714865-3CF88CF6-616F-47B6-80CB-72C38092FAF3

Q33714865-A15829C5-91B0-4ED7-BDA2-B6986000A54E

Q33714865-C7DF4635-2FA5-43DB-A446-312484D90D8C

Q33714865-DC462769-6FEA-458D-B58E-8D4FECB1B71E

Q33714865-FAD37ADB-AB7B-4D73-82B8-4382EFCBE16F

P2860

Q33714865-0D18562F-E789-4677-82BA-C1813547F726

Q33714865-141D412A-B1E3-4479-A75A-49A27B102FBD

Q33714865-160DC78C-FF74-4F57-B9E5-C63E1CA97652

Q33714865-433C0969-E14C-4840-A31A-498BC26D27FB

Q33714865-4CB32460-AEED-482B-BC03-F2A1220895FA

Q33714865-680745F5-148E-46A3-AD0A-8DE95975F7AA

Q33714865-69B69D2D-5B1F-4E46-BF39-D03CA90EB0AF

Q33714865-6D3F9E3D-7290-4E5D-B81A-544D48D698B4

Q33714865-79416D05-B240-402E-ABD3-C7ECAB6C67E5

Q33714865-7D79E4BE-A891-4280-AF92-65817E70C992

P304

Q33714865-2A4DD8AC-FCA9-45EB-8B7C-F6A90855E5B0

P31

Q33714865-5F2BC0B9-6D9E-49BF-B700-2582B3F75984

P356

Q33714865-38BDCA84-2D3D-4E35-8F65-C598154FFED9

P407

Q33714865-EB3181E6-A4D5-4B66-9121-7AFBCD79AC92

P433

Q33714865-AAD745D2-277E-4ADA-ADB4-677AF5273972

P478

Q33714865-7B24A076-E441-4E77-A82B-82970665E487

P577

Q33714865-8310124E-B2CC-4452-A59D-9D9BFBC88146

P5875

Q33714865-4A5E95BA-685F-4C2E-9629-CC4E728DFDC1

P698

Q33714865-D3556DF8-EFEF-4F4B-B0BF-590E70FDC108

P932

Q33714865-13EADE90-FFBD-4C1A-859D-4E1ADABB5573

P356

JPET.109.160937

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Combination therapy of 17beta- ...... r experimental ischemic stroke

@en

P2093

James W Simpkins

http://www.w3.org/2001/XMLSchema#string

Qing Liu

http://www.w3.org/2001/XMLSchema#string

Ran Liu

http://www.w3.org/2001/XMLSchema#string

Shao-Hua Yang

http://www.w3.org/2001/XMLSchema#string

Shaoqing He

http://www.w3.org/2001/XMLSchema#string

P2860

Rodent models of focal stroke: size, mechanism, and purpose

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.

Estrogen as a neuroprotectant in stroke.

New considerations in analyzing stroke and heart disease mortality trends: the Year 2000 Age Standard and the International Statistical Classification of Diseases and Related Health Problems, 10th Revision.

Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Animal models of focal and global cerebral ischemia.

Estrogen and ischemic neuroprotection: an integrated view.

Animal models of stroke: do they have value for discovering neuroprotective agents?

Triggers and mediators of hemorrhagic transformation in cerebral ischemia.

P304

1006-1012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.109.160937

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

332

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40045329

http://www.w3.org/2001/XMLSchema#string

P698

19952306

http://www.w3.org/2001/XMLSchema#string

P932

2835431

http://www.w3.org/2001/XMLSchema#string